Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study - Yang, H; Bouma, BJ; Dimopoulos, K (Int J Cardiol, 2020)
et al.